It helps adults and pediatric patients aged 12 years and older with obesity, or overweight accompanied by weight-related medical conditions, to lose weight and maintain reduction over time
As of May 2023, Ozempic and Wegovy are both listed on FDAs Drug Shortages list . When reached for comment on the matter, Novo Nordisk pointed to this press release concerning its recent filing of trademark infringement and false advertising suits against certain medical spas, weight loss or wellness clinics, and compounding pharmacies, that it alleges are unlawfully using its trademarked brand names Ozempic or Wegovy when marketing and/or selling compounded products purporting to contain semaglutide that are not genuine Ozempic or Wegovy products
This analysis will help determine if GLP-1 drugs should remain a part of the conversation for Alzheimers prevention, even if they are not the solution for treatment.
Do I need a prescription to purchase Wegovy
Shima Hadidchi, MD , provides guidance on qualifying for Semaglutide GLP-1 weight loss, generally recommended for patients with a BMI of 30+ or 27+ with weight-related health conditions